HR. 1525In Committee
Protecting Life from Chemical Abortions Act
Nullifies FDA changes to mifepristone dispensing rules, restricts loosening REMS protections, and generally bars abortion-related public health emergency declarations
Plain-English overview
What this bill does
Nullifies FDA changes to mifepristone dispensing rules, restricts loosening REMS protections, and generally bars abortion-related public health emergency declarations
Key points
- Prohibit reduced REMS protections
- Prohibit abortion emergency declarations
- Repeal FDA dispensing changes
Current status
Where it stands
Status
In Committee
Latest action
2025-02-24 — Referred to the House Committee on Energy and Commerce.
Related context
Topics and policy areas
undefinedAbortionDrug safety, medical device, and laboratory regulationDrug therapyGovernment information and archivesHealthHealth information and medical recordsPrescription drugs